These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1620191)

  • 21. Detection of prenatal drug exposure in the pregnant woman and her newborn infant.
    Ostrea EM
    NIDA Res Monogr; 1992; 117():61-79. PubMed ID: 1620211
    [No Abstract]   [Full Text] [Related]  

  • 22. [Children of drug addicts].
    Olofsson M
    Nord Med; 1982 Jan; 97(1):3-5. PubMed ID: 7058116
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cocaine and pregnancy; who pays the bill?].
    van den Anker JN; Mildner RJ; Sauer PJ
    Ned Tijdschr Geneeskd; 1993 Jan; 137(3):118-21. PubMed ID: 8423859
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis and use of qualitative data.
    Sidani S; Sechrest L
    NIDA Res Monogr; 1996; 166():292-309. PubMed ID: 8818179
    [No Abstract]   [Full Text] [Related]  

  • 25. Discussion: effect of legal stipulations on the conduct of treatment and prevention research.
    Howard J
    NIDA Res Monogr; 1992; 117():385-93. PubMed ID: 1620209
    [No Abstract]   [Full Text] [Related]  

  • 26. Issues in subject recruitment and retention with pregnant and parenting substance-abusing women.
    Howard J; Beckwith L
    NIDA Res Monogr; 1996; 166():68-86. PubMed ID: 8818166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Building bridges: treatment research partnerships in the community.
    Chasnoff IJ; Marques PR; Strantz IH; Farrow J; Davis S
    NIDA Res Monogr; 1996; 166():6-21. PubMed ID: 8818162
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pregnancy care in drug-dependent patients under the charge of SERT (Public Service for the Treatment of Drug Addiction) of Massa-Carrara. The prevention of fetal damages and premature labor].
    Damone R; Angelotti L; Giusti P; Luzzoli RM; Previtera G; Zannoni C; Migliorini P
    Epidemiol Prev; 1996; 20(2-3):86-8. PubMed ID: 8766282
    [No Abstract]   [Full Text] [Related]  

  • 29. Prenatal exposure to drugs of abuse: methodological considerations and effects on sexual differentiation.
    McGivern RF; Handa RJ
    NIDA Res Monogr; 1996; 164():78-124. PubMed ID: 8809869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug dependence in obstetrics and gynecology].
    Meriggi E; Mansueto MG
    Minerva Ginecol; 1980 Mar; 32(3):143-56. PubMed ID: 6990309
    [No Abstract]   [Full Text] [Related]  

  • 31. Measuring prenatal drug exposure.
    Bergin C; Cameron CE; Fleitz RS; Patel AV
    J Pediatr Nurs; 2001 Aug; 16(4):245-55. PubMed ID: 11498817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gynecological-obstetrical problems in female drug users and drug addicts].
    Zumbé FJ; Beck KJ; Schönhöfer PS
    Geburtshilfe Frauenheilkd; 1973 Apr; 33(4):241-53. PubMed ID: 4710014
    [No Abstract]   [Full Text] [Related]  

  • 33. Cocaine: a primer for providers of perinatal care.
    Holland JG; Graves GR; Martin JN
    J Miss State Med Assoc; 1990 Sep; 31(9):287-93. PubMed ID: 2213877
    [No Abstract]   [Full Text] [Related]  

  • 34. Ethylene glycol and other solvent use in pregnancy: a new phenomenon and a new diagnostic dilemma.
    Kuczkowski KM
    Acta Anaesthesiol Scand; 2006 Sep; 50(8):1037. PubMed ID: 16923104
    [No Abstract]   [Full Text] [Related]  

  • 35. Case management: a method of addressing subject selection and recruitment issues.
    LaFazia MA; Kleyn J; Lanz J; Hall T; Nyrop K; Stark KD; Hansen C; Watts DH
    NIDA Res Monogr; 1996; 166():52-67. PubMed ID: 8818165
    [No Abstract]   [Full Text] [Related]  

  • 36. Maternal-fetal cardiovascular system: a target of cocaine.
    Woods JR; Plessinger MA
    NIDA Res Monogr; 1991; 108():7-27. PubMed ID: 1749418
    [No Abstract]   [Full Text] [Related]  

  • 37. Recruitment and retention of adolescent women in drug treatment research.
    Palinkas LA; Atkins CJ; Noel P; Miller C
    NIDA Res Monogr; 1996; 166():87-109. PubMed ID: 8818167
    [No Abstract]   [Full Text] [Related]  

  • 38. Measurement of substance use during pregnancy: methodologic issues.
    Day NL; Wagener DK; Taylor PM
    NIDA Res Monogr; 1985; 59():36-47. PubMed ID: 3929131
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and chemico-toxicological considerations on newborn infants of drug-addicted mothers].
    Brunelli L; Lodi F
    Minerva Pediatr; 1980 Dec; 32(23):1331-4. PubMed ID: 7219374
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pregnancy and psychoactives substances: prevalence study based on the declared consumption].
    Dumas A; Lejeune C; Simmat-Durand L; Crenn-Hébert C; Mandelbrot L
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37(8):770-8. PubMed ID: 18667282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.